Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

New Workstation Provides Superior Pipetting Performance with Advanced Technologies

By BiotechDaily International staff writers
Posted on 01 Oct 2013
Image: The new VANTAGE liquid handling workstation from Hamilton Robotics (Photo courtesy of Hamilton Robotics).
Image: The new VANTAGE liquid handling workstation from Hamilton Robotics (Photo courtesy of Hamilton Robotics).
A new liquid handling platform provides superior performance for simple to complex pipetting needs, plus an integration option to simplify laboratory automation.

Hamilton Robotics (Reno, NV, USA) now offers the “Vantage” workstation, a highly flexible, multipurpose pipetting platform featuring a completely new, state-of-the-art linear motor design and contact-free NanoPulse pipetting technology covering a wide volume range (100 nL–1 mL). This affordable liquid handler is space-efficient and enables users to prepare samples with the utmost precision and traceability, helping to ensure downstream data reliability.


"The Hamilton VANTAGE caters to all market needs, from a low-cost pipettor to the most complex integrated system, and is field upgradable to cover the entire usability pyramid," said Jose Carle, vice president of Hamilton Robotics. Its expandable design also makes it a valuable instrument for labs with growing needs or new applications. Labs requiring increased walk-away time, high throughputs, or large capacities can upgrade their bench-top VANTAGE pipettor at any time with a Logistics Cabinet, which offers innovative tip and plate shuttling from below the pipetting deck and customizable, smart waste solutions.


A telescopic, vertical Track Gripper can also be added to transport samples from below- or off-deck third-party devices such as thermal cyclers, centrifuges, washers, readers, sealers, peelers, and incubators. "A single vertically integrated system can easily replace four to six other pipetting robots and offers much more functionality than competitor's platforms," said Alvaro Cuevas, VANTAGE Senior Product Manager. “Overall, this saves customers money and enables them to build process redundancy with a second robot at the same price point."


In addition to the hardware, INSTINCT V software brings ease of use to the next level with automation intelligence, making VANTAGE accessible to varying user levels. The graphical Assay Editor allows a user to program in a "lab person's language" while the XSL Editor can be used for more complex programming tasks. INSTINCT V's resource-optimized, dynamic Scheduler allows users to run the same or different assays in parallel on an instrument while other users connect remotely to write methods for new assays. INSTINCT V also provides remote system monitoring via smart phones, tablets, or any web-enabled device, which increases walk-away time for overnight and weekend runs.

Related Links:
Hamilton Robotics
VANTAGE Workstation




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: The new peptide offers a triple hormone effect in a single-cell molecule (Photo courtesy of Indiana University).

Tripeptide Drug Effectively Controls Metabolic Syndrome in Rodent Model

Promising results in reducing obesity and normalizing glucose metabolism obtained with a synthetic dipeptide drug have been enhanced by the addition of a molecule of a third hormone, glucagon.... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.